- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Human tumour necrosis factor alfa-derived peptide Cys-Gly-Gl
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Human tumour necrosis factor alfa-derived peptide Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys
| EU orphan designation number: | EU/3/09/677
|
| Active ingredient: | Human tumour necrosis factor alfa-derived peptide Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys |
| Indication: | Treatment of acute lung injury |
| Sponsor: | Apeptico Forschung und Entwicklung GmbH
Mariahilferstraße 136, A-1150 Wien, Österreich |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 12/10/2009 | Orphan designation | EMEA/OD/015/09 | (2009)7860 of 08/10/2009 |
CONTACT
EU links
Directorate General Health & Consumers